Cochlear (COH) Share Forecast & Price Target

Compare

93 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

COH Analyst Ratings

Moderate Buy

4 Buy

5 Hold

1 Sell

Based on 10 analysts giving stock ratings to

Cochlear

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

COH Stock 12 Month Forecast

Average Price Target

AU$254.34

▲(27.80% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Cochlear in the last 3 months. The average price target is AU$254.34 with a high forecast of AU$304.00 and a low forecast of AU$210.00. The average price target represents a 27.80% change from the last price of AU$199.01.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"209":"AU$209","262":"AU$262","315":"AU$315","235.5":"AU$235.5","288.5":"AU$288.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":304.00000096368,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$304.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":254.3420134734,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$254.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":210.0000006657,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$210.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[209,235.5,262,288.5,315],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,266.15,269.0615385356677,271.97307707133535,274.88461560700307,277.79615414267073,280.70769267833845,283.61923121400616,286.5307697496738,289.44230828534154,292.35384682100926,295.2653853566769,298.17692389234463,301.0884624280123,{"y":304.00000096368,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,266.15,265.24169334410766,264.33338668821534,263.4250800323231,262.51677337643076,261.60846672053844,260.7001600646461,259.7918534087538,258.88354675286155,257.97524009696923,257.0669334410769,256.1586267851846,255.2503201292923,{"y":254.3420134734,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,266.15,261.8307692819769,257.5115385639538,253.19230784593074,248.87307712790766,244.55384640988459,240.2346156918615,235.91538497383846,231.59615425581535,227.2769235377923,222.9576928197692,218.63846210174614,214.31923138372306,{"y":210.0000006657,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":314.777,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.929,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":263.085,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.613,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":269.756,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":302.348,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":310.061,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":298.466,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 43, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":278.99,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 62, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":287.16,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 47, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.27,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":260.66,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":266.15,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 56, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetAU$304.00

Average Price TargetAU$254.34

Lowest Price TargetAU$210.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Shane Storey

Canaccord Genuity

AU$330→AU$295

Buy

48.23%

Upside

Reiterated

02/17/26

Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (NASDAQ: EYPT), Cochlear (Other OTC: CHEOF) and Disc Medicine (NASDAQ: IRON)

David Low

UBS

AU$302

Buy

51.75%

Upside

Reiterated

02/16/26

UBS Sticks to Its Buy Rating for Cochlear (CHEOF)

David Bailey

Morgan Stanley

AU$270→AU$216

Sell

8.54%

Upside

Reiterated

02/16/26

Cochlear (CHEOF) Gets a Sell from Morgan Stanley

Laura Sutcliffe

Citi

AU$300→AU$210

Hold

5.52%

Upside

Reiterated

02/16/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Cochlear (Other OTC: CHEOF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

AU$281→AU$241.5

Hold

21.35%

Upside

Reiterated

02/16/26

Ord Minnett Keeps Their Hold Rating on Cochlear (CHEOF)

Derek Jellinek

Morgans

AU$214.93

Hold

8.00%

Upside

Upgraded

02/15/26

Morgans upgrades Cochlear (CHEOF) to a Hold

Unknown Analyst

Macquarie

Not Ranked

Macquarie

AU$295.9→AU$239

Hold

20.09%

Upside

Reiterated

02/15/26

Cochlear (CHEOF) Gets a Hold from Macquarie

David Stanton

Jefferies

AU$304

Buy

52.76%

Upside

Reiterated

02/13/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Steven Wheen

Jarden

AU$224

Hold

12.56%

Upside

Reiterated

02/13/26

Cochlear (CHEOF) Receives a Hold from Jarden

Craig Wong-Pan

RBC Capital

AU$325→AU$297

Buy

49.24%

Upside

Reiterated

02/13/26

Cochlear (CHEOF) Gets a Buy from RBC Capital

Davinthra Thillainathan

Goldman Sachs

―

Hold

―

Reiterated

06/14/25

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM) and Cochlear (Other OTC: CHEOF)

Andrew Paine

CLSA

AU$282.5→AU$290

Buy

45.72%

Upside

Upgraded

03/17/25

CLSA Upgrades Cochlear Ltd. (COH:AU) (CHEOY) to Outperform (2)CLSA analyst Andrew Paine upgraded Cochlear Ltd. (COH:AU) (OTC: CHEOY) from Hold (3) to Outperform (2) with a price target of AUD290.00 (from AUD282.50).

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Shane Storey

Canaccord Genuity

AU$330→AU$295

Buy

48.23%

Upside

Reiterated

02/17/26

Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (NASDAQ: EYPT), Cochlear (Other OTC: CHEOF) and Disc Medicine (NASDAQ: IRON)

David Low

UBS

AU$302

Buy

51.75%

Upside

Reiterated

02/16/26

UBS Sticks to Its Buy Rating for Cochlear (CHEOF)

David Bailey

Morgan Stanley

AU$270→AU$216

Sell

8.54%

Upside

Reiterated

02/16/26

Cochlear (CHEOF) Gets a Sell from Morgan Stanley

Laura Sutcliffe

Citi

AU$300→AU$210

Hold

5.52%

Upside

Reiterated

02/16/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Cochlear (Other OTC: CHEOF)

Unknown Analyst

Ord Minnett

Not Ranked

Ord Minnett

AU$281→AU$241.5

Hold

21.35%

Upside

Reiterated

02/16/26

Ord Minnett Keeps Their Hold Rating on Cochlear (CHEOF)

Derek Jellinek

Morgans

AU$214.93

Hold

8.00%

Upside

Upgraded

02/15/26

Morgans upgrades Cochlear (CHEOF) to a Hold

Unknown Analyst

Macquarie

Not Ranked

Macquarie

AU$295.9→AU$239

Hold

20.09%

Upside

Reiterated

02/15/26

Cochlear (CHEOF) Gets a Hold from Macquarie

David Stanton

Jefferies

AU$304

Buy

52.76%

Upside

Reiterated

02/13/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Steven Wheen

Jarden

AU$224

Hold

12.56%

Upside

Reiterated

02/13/26

Cochlear (CHEOF) Receives a Hold from Jarden

Craig Wong-Pan

RBC Capital

AU$325→AU$297

Buy

49.24%

Upside

Reiterated

02/13/26

Cochlear (CHEOF) Gets a Buy from RBC Capital

Davinthra Thillainathan

Goldman Sachs

―

Hold

―

Reiterated

06/14/25

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM) and Cochlear (Other OTC: CHEOF)

Andrew Paine

CLSA

AU$282.5→AU$290

Buy

45.72%

Upside

Upgraded

03/17/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cochlear

3 Months

xxx

Success Rate

4/7 ratings generated profit

Average Return

+0.60%

upgraded a xxx

rating 12 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +0.60% per trade.

1 Year

David StantonJefferies

Success Rate

3/7 ratings generated profit

Average Return

-10.73%

reiterated a buy rating 17 days ago

Copying David Stanton's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -10.73% per trade.

2 Years

xxx

Success Rate

3/7 ratings generated profit

Average Return

-10.37%

upgraded a xxx

rating 12 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of -10.37% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

COH Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, COH has received 5 Buy Ratings, 56 Hold Ratings, and 2 Sell Ratings. COH average Analyst price target in the past 3 months is 254.34.

Each month's total comprises the sum of three months' worth of ratings.

COH Financial Forecast

COH Earnings Forecast

Next quarter’s earnings estimate for COH is AU$3.35 with a range of AU$3.10 to AU$3.67. The previous quarter’s EPS was AU$2.98. COH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year COH has Performed in-line its overall industry.

COH Sales Forecast

Next quarter’s sales forecast for COH is AU$1.30B with a range of AU$1.25B to AU$1.36B. The previous quarter’s sales results were AU$1.18B. COH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year COH has Performed in-line its overall industry.

COH Stock Forecast FAQ

What is AU:COH’s average 12-month price target, according to analysts?

Based on analyst ratings, Cochlear Limited’s 12-month average price target is 254.34.

What is AU:COH’s upside potential, based on the analysts’ average price target?

Cochlear Limited has 27.80% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Cochlear Limited a Buy, Sell or Hold?

Cochlear Limited has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 5 hold ratings and 1 sell ratings.

What is Cochlear Limited’s share price target?

The average share price target for Cochlear Limited is 254.34. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$304.00 ,and the lowest forecast is AU$210.00. The average share price target represents 27.80% Increase from the current price of AU$199.01.

What do analysts say about Cochlear Limited?

Cochlear Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Cochlear Limited?

To buy shares of AU:COH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Cochlear (COH) Share Forecast & Price Target

COH Analyst Ratings

COH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cochlear

COH Analyst Recommendation Trends

COH Financial Forecast

COH Earnings Forecast

COH Sales Forecast

COH Stock Forecast FAQ

Detailed List of Analyst Forecasts